Following the arrival of 1,000 additional Marburg vaccines from the Sabin Vaccine Institute on October 12, Rwanda is intensifying its vaccination efforts, targeting healthcare workers and high-risk groups, particularly those in intensive care units (ICUs).
During a briefing on the outbreak, Minister of Health Dr. Sabin Nsanzimana reported that over 600 people have already been vaccinated from the initial batch of 700 doses, with the new shipment further supporting the country’s response to the virus.
He emphasized that vaccinating those most at risk is crucial for both their health and public safety.
Dr. Nsanzimana explained that the vaccination campaign is now in its second phase, focusing on the efficacy of the vaccine.
“This phase differs from the first, which tested safety. The vaccine has been proven safe in both the US and East Africa, and we are confident in its benefits,” he said.
Most of the vaccine recipients are healthcare professionals who are well-informed about its advantages and potential side effects.
Since the outbreak began on September 27, Rwanda has recorded 61 confirmed cases of the Marburg virus, resulting in 14 deaths.
However, Dr. Nsanzimana noted that 18 people have recovered, and 29 are still undergoing treatment, with three in critical condition.
The Minister expressed optimism about containing the virus, stating that the number of recoveries now surpasses the deaths, signaling the positive impact of the country’s efforts. He assured that patients are receiving the best possible care with support from local and international experts.